Comparison of Hyperemic Efficacy Between Nicorandil and Adenosine for Fractional Flow Reserve (FFR) Measurement

A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 200 participants.

Also called NCT01331902

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; single masking; primary purpose diagnostic
Phase
Phase 4
Enrolled
  • 200 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT01331902
Start date
(registry gives no type) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
South Korea (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT01331902. Randomized; single masking; primary purpose diagnostic. Start 2011-03 (registry gives no type); primary completion 2011-09 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Comparison of Hyperemic Efficacy Between Nicorandil and Adenosine for Fractional Flow Reserve (FFR) Measurement
Condition
Myocardial Ischemia
Intervention (Other)
Maximal Hyperemia with Adenosine Followed by Nicorandil
Intervention (Other)
Maximal Hyperemia with Nicorandil Followed by Adenosine
Lead sponsor
Seoul National University Hospital (class: other)
Collaborator
Seoul National University Boramae Hospital (class: other)
Collaborator
Inje University Ilsan Paik Hospital (class: other)
Collaborator
Keimyung University Dongsan Medical Center (class: other)

Record details

Record id
cardio:ct-nct01331902
Content hash
0825b1c16ffe2b3cfe0f51ac78d4cd0c1db187fdfb6003a817d2dec9802de263